 | • レポートコード：QY2112C03910 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は血漿由来医薬品の世界市場の現状について調査・分析し、2027年までの市場を予測しました。血漿由来医薬品の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（免疫グロブリン、凝固因子濃縮物、その他）、用途別市場規模（救急医療、エピデミック疾患、免疫系障害、抗体欠乏症、凝固障害、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・血漿由来医薬品の世界市場概要 ・メーカー別の競争状況、市場シェア ・血漿由来医薬品の種類別市場規模：免疫グロブリン、凝固因子濃縮物、その他 ・血漿由来医薬品の用途別市場規模：救急医療、エピデミック疾患、免疫系障害、抗体欠乏症、凝固障害、その他 ・北米の血漿由来医薬品市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの血漿由来医薬品市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの血漿由来医薬品市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の血漿由来医薬品市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの血漿由来医薬品市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Novartis(CSL Limited)、Biotest AG (Creat Group Corporation)、Grifols SA、Sigma-Aldrich、Thermo Fisher Scientific、Octapharma AG、Takeda、Kedrion、China Biologic Products、LFB Group ・血漿由来医薬品のバリューチェーン・販売チャネル分析 ・血漿由来医薬品の世界市場動向 |
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
Market Analysis and Insights: Global Plasma-derived Medicinal Products Market
The global Plasma-derived Medicinal Products market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
Global Plasma-derived Medicinal Products Scope and Segment
Plasma-derived Medicinal Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma-derived Medicinal Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other
Segment by Application
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
By Company
Novartis(CSL Limited)
Biotest AG (Creat Group Corporation)
Grifols SA
Sigma-Aldrich
Thermo Fisher Scientific
Octapharma AG
Takeda
Kedrion
China Biologic Products
LFB Group
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Plasma-derived Medicinal Products Product Introduction
1.2 Market by Type
1.2.1 Global Plasma-derived Medicinal Products Market Size Growth Rate by Type
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market by Application
1.3.1 Global Plasma-derived Medicinal Products Market Size Growth Rate by Application
1.3.2 Emergency Care
1.3.3 Epidemic Diseasae
1.3.4 Immune System Disorder
1.3.5 Antibody Deficiency
1.3.6 Coagulation Disorder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts 2016-2027
2.2 Global Plasma-derived Medicinal Products Revenue Estimates and Forecasts 2016-2027
2.3 Global Plasma-derived Medicinal Products Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Plasma-derived Medicinal Products Regions by Sales
2.4.1 Global Top Plasma-derived Medicinal Products Regions by Sales (2016-2021)
2.4.2 Global Top Plasma-derived Medicinal Products Regions by Sales (2022-2027)
2.5 Global Top Plasma-derived Medicinal Products Regions by Revenue
2.5.1 Global Top Plasma-derived Medicinal Products Regions by Revenue (2016-2021)
2.5.2 Global Top Plasma-derived Medicinal Products Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Plasma-derived Medicinal Products Sales by Manufacturers
3.1.1 Global Top Plasma-derived Medicinal Products Manufacturers by Sales (2016-2021)
3.1.2 Global Top Plasma-derived Medicinal Products Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Plasma-derived Medicinal Products Sales in 2020
3.2 Global Plasma-derived Medicinal Products Revenue by Manufacturers
3.2.1 Global Top Plasma-derived Medicinal Products Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Plasma-derived Medicinal Products Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Plasma-derived Medicinal Products Revenue in 2020
3.3 Global Plasma-derived Medicinal Products Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plasma-derived Medicinal Products Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma-derived Medicinal Products Sales by Type
4.1.1 Global Plasma-derived Medicinal Products Historical Sales by Type (2016-2021)
4.1.2 Global Plasma-derived Medicinal Products Forecasted Sales by Type (2022-2027)
4.1.3 Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
4.2 Global Plasma-derived Medicinal Products Revenue by Type
4.2.1 Global Plasma-derived Medicinal Products Historical Revenue by Type (2016-2021)
4.2.2 Global Plasma-derived Medicinal Products Forecasted Revenue by Type (2022-2027)
4.2.3 Global Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
4.3 Global Plasma-derived Medicinal Products Price by Type
4.3.1 Global Plasma-derived Medicinal Products Price by Type (2016-2021)
4.3.2 Global Plasma-derived Medicinal Products Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Plasma-derived Medicinal Products Sales by Application
5.1.1 Global Plasma-derived Medicinal Products Historical Sales by Application (2016-2021)
5.1.2 Global Plasma-derived Medicinal Products Forecasted Sales by Application (2022-2027)
5.1.3 Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
5.2 Global Plasma-derived Medicinal Products Revenue by Application
5.2.1 Global Plasma-derived Medicinal Products Historical Revenue by Application (2016-2021)
5.2.2 Global Plasma-derived Medicinal Products Forecasted Revenue by Application (2022-2027)
5.2.3 Global Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
5.3 Global Plasma-derived Medicinal Products Price by Application
5.3.1 Global Plasma-derived Medicinal Products Price by Application (2016-2021)
5.3.2 Global Plasma-derived Medicinal Products Price Forecast by Application (2022-2027)
6 North America
6.1 North America Plasma-derived Medicinal Products Market Size by Type
6.1.1 North America Plasma-derived Medicinal Products Sales by Type (2016-2027)
6.1.2 North America Plasma-derived Medicinal Products Revenue by Type (2016-2027)
6.2 North America Plasma-derived Medicinal Products Market Size by Application
6.2.1 North America Plasma-derived Medicinal Products Sales by Application (2016-2027)
6.2.2 North America Plasma-derived Medicinal Products Revenue by Application (2016-2027)
6.3 North America Plasma-derived Medicinal Products Market Size by Country
6.3.1 North America Plasma-derived Medicinal Products Sales by Country (2016-2027)
6.3.2 North America Plasma-derived Medicinal Products Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Plasma-derived Medicinal Products Market Size by Type
7.1.1 Europe Plasma-derived Medicinal Products Sales by Type (2016-2027)
7.1.2 Europe Plasma-derived Medicinal Products Revenue by Type (2016-2027)
7.2 Europe Plasma-derived Medicinal Products Market Size by Application
7.2.1 Europe Plasma-derived Medicinal Products Sales by Application (2016-2027)
7.2.2 Europe Plasma-derived Medicinal Products Revenue by Application (2016-2027)
7.3 Europe Plasma-derived Medicinal Products Market Size by Country
7.3.1 Europe Plasma-derived Medicinal Products Sales by Country (2016-2027)
7.3.2 Europe Plasma-derived Medicinal Products Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma-derived Medicinal Products Market Size by Type
8.1.1 Asia Pacific Plasma-derived Medicinal Products Sales by Type (2016-2027)
8.1.2 Asia Pacific Plasma-derived Medicinal Products Revenue by Type (2016-2027)
8.2 Asia Pacific Plasma-derived Medicinal Products Market Size by Application
8.2.1 Asia Pacific Plasma-derived Medicinal Products Sales by Application (2016-2027)
8.2.2 Asia Pacific Plasma-derived Medicinal Products Revenue by Application (2016-2027)
8.3 Asia Pacific Plasma-derived Medicinal Products Market Size by Region
8.3.1 Asia Pacific Plasma-derived Medicinal Products Sales by Region (2016-2027)
8.3.2 Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Plasma-derived Medicinal Products Market Size by Type
9.1.1 Latin America Plasma-derived Medicinal Products Sales by Type (2016-2027)
9.1.2 Latin America Plasma-derived Medicinal Products Revenue by Type (2016-2027)
9.2 Latin America Plasma-derived Medicinal Products Market Size by Application
9.2.1 Latin America Plasma-derived Medicinal Products Sales by Application (2016-2027)
9.2.2 Latin America Plasma-derived Medicinal Products Revenue by Application (2016-2027)
9.3 Latin America Plasma-derived Medicinal Products Market Size by Country
9.3.1 Latin America Plasma-derived Medicinal Products Sales by Country (2016-2027)
9.3.2 Latin America Plasma-derived Medicinal Products Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Plasma-derived Medicinal Products Market Size by Type
10.1.1 Middle East and Africa Plasma-derived Medicinal Products Sales by Type (2016-2027)
10.1.2 Middle East and Africa Plasma-derived Medicinal Products Revenue by Type (2016-2027)
10.2 Middle East and Africa Plasma-derived Medicinal Products Market Size by Application
10.2.1 Middle East and Africa Plasma-derived Medicinal Products Sales by Application (2016-2027)
10.2.2 Middle East and Africa Plasma-derived Medicinal Products Revenue by Application (2016-2027)
10.3 Middle East and Africa Plasma-derived Medicinal Products Market Size by Country
10.3.1 Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2016-2027)
10.3.2 Middle East and Africa Plasma-derived Medicinal Products Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis(CSL Limited)
11.1.1 Novartis(CSL Limited) Corporation Information
11.1.2 Novartis(CSL Limited) Overview
11.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Novartis(CSL Limited) Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis(CSL Limited) Recent Developments
11.2 Biotest AG (Creat Group Corporation)
11.2.1 Biotest AG (Creat Group Corporation) Corporation Information
11.2.2 Biotest AG (Creat Group Corporation) Overview
11.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biotest AG (Creat Group Corporation) Recent Developments
11.3 Grifols SA
11.3.1 Grifols SA Corporation Information
11.3.2 Grifols SA Overview
11.3.3 Grifols SA Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Grifols SA Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols SA Recent Developments
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Corporation Information
11.4.2 Sigma-Aldrich Overview
11.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sigma-Aldrich Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sigma-Aldrich Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Overview
11.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Thermo Fisher Scientific Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Octapharma AG
11.6.1 Octapharma AG Corporation Information
11.6.2 Octapharma AG Overview
11.6.3 Octapharma AG Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Octapharma AG Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Octapharma AG Recent Developments
11.7 Takeda
11.7.1 Takeda Corporation Information
11.7.2 Takeda Overview
11.7.3 Takeda Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Takeda Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Recent Developments
11.8 Kedrion
11.8.1 Kedrion Corporation Information
11.8.2 Kedrion Overview
11.8.3 Kedrion Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Kedrion Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kedrion Recent Developments
11.9 China Biologic Products
11.9.1 China Biologic Products Corporation Information
11.9.2 China Biologic Products Overview
11.9.3 China Biologic Products Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 China Biologic Products Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China Biologic Products Recent Developments
11.10 LFB Group
11.10.1 LFB Group Corporation Information
11.10.2 LFB Group Overview
11.10.3 LFB Group Plasma-derived Medicinal Products Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 LFB Group Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 LFB Group Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Plasma-derived Medicinal Products Value Chain Analysis
12.2 Plasma-derived Medicinal Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma-derived Medicinal Products Production Mode & Process
12.4 Plasma-derived Medicinal Products Sales and Marketing
12.4.1 Plasma-derived Medicinal Products Sales Channels
12.4.2 Plasma-derived Medicinal Products Distributors
12.5 Plasma-derived Medicinal Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plasma-derived Medicinal Products Industry Trends
13.2 Plasma-derived Medicinal Products Market Drivers
13.3 Plasma-derived Medicinal Products Market Challenges
13.4 Plasma-derived Medicinal Products Market Restraints
14 Key Findings in The Global Plasma-derived Medicinal Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Plasma-derived Medicinal Products Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Immunoglobulins
Table 3. Major Manufacturers of Coagulation Factor Concentrates
Table 4. Major Manufacturers of Other
Table 5. Global Plasma-derived Medicinal Products Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Plasma-derived Medicinal Products Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Plasma-derived Medicinal Products Sales by Region (2016-2021) & (K Units)
Table 8. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2021)
Table 9. Global Plasma-derived Medicinal Products Sales by Region (2022-2027) & (K Units)
Table 10. Global Plasma-derived Medicinal Products Sales Market Share by Region (2022-2027)
Table 11. Global Plasma-derived Medicinal Products Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2021)
Table 13. Global Plasma-derived Medicinal Products Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2022-2027)
Table 15. Global Plasma-derived Medicinal Products Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Plasma-derived Medicinal Products Sales Share by Manufacturers (2016-2021)
Table 17. Global Plasma-derived Medicinal Products Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2016-2021)
Table 19. Plasma-derived Medicinal Products Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Plasma-derived Medicinal Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Plasma-derived Medicinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2020)
Table 22. Plasma-derived Medicinal Products Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Plasma-derived Medicinal Products Product Offered
Table 24. Date of Manufacturers Enter into Plasma-derived Medicinal Products Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 27. Global Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 28. Global Plasma-derived Medicinal Products Sales Share by Type (2016-2021)
Table 29. Global Plasma-derived Medicinal Products Sales Share by Type (2022-2027)
Table 30. Global Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Plasma-derived Medicinal Products Revenue Share by Type (2016-2021)
Table 33. Global Plasma-derived Medicinal Products Revenue Share by Type (2022-2027)
Table 34. Plasma-derived Medicinal Products Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Plasma-derived Medicinal Products Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 37. Global Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 38. Global Plasma-derived Medicinal Products Sales Share by Application (2016-2021)
Table 39. Global Plasma-derived Medicinal Products Sales Share by Application (2022-2027)
Table 40. Global Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Plasma-derived Medicinal Products Revenue Share by Application (2016-2021)
Table 43. Global Plasma-derived Medicinal Products Revenue Share by Application (2022-2027)
Table 44. Plasma-derived Medicinal Products Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Plasma-derived Medicinal Products Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 47. North America Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 48. North America Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 51. North America Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 52. North America Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 55. North America Plasma-derived Medicinal Products Sales by Country (2022-2027) & (K Units)
Table 56. North America Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Plasma-derived Medicinal Products Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 59. Europe Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 60. Europe Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 63. Europe Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 64. Europe Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 67. Europe Plasma-derived Medicinal Products Sales by Country (2022-2027) & (K Units)
Table 68. Europe Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Plasma-derived Medicinal Products Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Plasma-derived Medicinal Products Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Plasma-derived Medicinal Products Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Plasma-derived Medicinal Products Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Plasma-derived Medicinal Products Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Plasma-derived Medicinal Products Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Plasma-derived Medicinal Products Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Plasma-derived Medicinal Products Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Plasma-derived Medicinal Products Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Plasma-derived Medicinal Products Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Plasma-derived Medicinal Products Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Plasma-derived Medicinal Products Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Plasma-derived Medicinal Products Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Plasma-derived Medicinal Products Revenue by Country (2022-2027) & (US$ Million)
Table 106. Novartis(CSL Limited) Corporation Information
Table 107. Novartis(CSL Limited) Description and Major Businesses
Table 108. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Novartis(CSL Limited) Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novartis(CSL Limited) Recent Developments
Table 111. Biotest AG (Creat Group Corporation) Corporation Information
Table 112. Biotest AG (Creat Group Corporation) Description and Major Businesses
Table 113. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Biotest AG (Creat Group Corporation) Recent Developments
Table 116. Grifols SA Corporation Information
Table 117. Grifols SA Description and Major Businesses
Table 118. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Grifols SA Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Grifols SA Recent Developments
Table 121. Sigma-Aldrich Corporation Information
Table 122. Sigma-Aldrich Description and Major Businesses
Table 123. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Sigma-Aldrich Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sigma-Aldrich Recent Developments
Table 126. Thermo Fisher Scientific Corporation Information
Table 127. Thermo Fisher Scientific Description and Major Businesses
Table 128. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Thermo Fisher Scientific Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Thermo Fisher Scientific Recent Developments
Table 131. Octapharma AG Corporation Information
Table 132. Octapharma AG Description and Major Businesses
Table 133. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Octapharma AG Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Octapharma AG Recent Developments
Table 136. Takeda Corporation Information
Table 137. Takeda Description and Major Businesses
Table 138. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Takeda Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Takeda Recent Developments
Table 141. Kedrion Corporation Information
Table 142. Kedrion Description and Major Businesses
Table 143. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Kedrion Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Kedrion Recent Developments
Table 146. China Biologic Products Corporation Information
Table 147. China Biologic Products Description and Major Businesses
Table 148. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. China Biologic Products Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. China Biologic Products Recent Developments
Table 151. LFB Group Corporation Information
Table 152. LFB Group Description and Major Businesses
Table 153. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. LFB Group Plasma-derived Medicinal Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. LFB Group Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Plasma-derived Medicinal Products Distributors List
Table 159. Plasma-derived Medicinal Products Customers List
Table 160. Plasma-derived Medicinal Products Market Trends
Table 161. Plasma-derived Medicinal Products Market Drivers
Table 162. Plasma-derived Medicinal Products Market Challenges
Table 163. Plasma-derived Medicinal Products Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma-derived Medicinal Products Product Picture
Figure 2. Global Plasma-derived Medicinal Products Market Share by Type in 2020 & 2027
Figure 3. Immunoglobulins Product Picture
Figure 4. Coagulation Factor Concentrates Product Picture
Figure 5. Other Product Picture
Figure 6. Global Plasma-derived Medicinal Products Market Share by Application in 2020 & 2027
Figure 7. Emergency Care
Figure 8. Epidemic Diseasae
Figure 9. Immune System Disorder
Figure 10. Antibody Deficiency
Figure 11. Coagulation Disorder
Figure 12. Others
Figure 13. Plasma-derived Medicinal Products Report Years Considered
Figure 14. Global Plasma-derived Medicinal Products Sales 2016-2027 (K Units)
Figure 15. Global Plasma-derived Medicinal Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Plasma-derived Medicinal Products Revenue 2016-2027 (US$ Million)
Figure 17. Global Plasma-derived Medicinal Products Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2021)
Figure 19. Global Plasma-derived Medicinal Products Sales Market Share by Region (2022-2027)
Figure 20. North America Plasma-derived Medicinal Products Sales YoY (2016-2027) & (K Units)
Figure 21. North America Plasma-derived Medicinal Products Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe Plasma-derived Medicinal Products Sales YoY (2016-2027) & (K Units)
Figure 23. Europe Plasma-derived Medicinal Products Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Asia-Pacific Plasma-derived Medicinal Products Sales YoY (2016-2027) & (K Units)
Figure 25. Asia-Pacific Plasma-derived Medicinal Products Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Latin America Plasma-derived Medicinal Products Sales YoY (2016-2027) & (K Units)
Figure 27. Latin America Plasma-derived Medicinal Products Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Middle East & Africa Plasma-derived Medicinal Products Sales YoY (2016-2027) & (K Units)
Figure 29. Middle East & Africa Plasma-derived Medicinal Products Revenue YoY (2016-2027) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Plasma-derived Medicinal Products Sales in 2020
Figure 31. The Top 10 and Top 5 Players Market Share by Plasma-derived Medicinal Products Revenue in 2020
Figure 32. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 33. Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 34. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 35. Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 36. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 37. North America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 38. North America Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 39. North America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 40. North America Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 41. North America Plasma-derived Medicinal Products Sales Share by Country (2016-2027)
Figure 42. North America Plasma-derived Medicinal Products Revenue Share by Country (2016-2027)
Figure 43. United States Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 44. Canada Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 45. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 46. Europe Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 47. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 48. Europe Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 49. Europe Plasma-derived Medicinal Products Sales Share by Country (2016-2027)
Figure 50. Europe Plasma-derived Medicinal Products Revenue Share by Country (2016-2027)
Figure 51. Germany Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 52. France Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 53. U.K. Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 54. Italy Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 55. Russia Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 56. Asia Pacific Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 57. Asia Pacific Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 58. Asia Pacific Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 59. Asia Pacific Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 60. Asia Pacific Plasma-derived Medicinal Products Sales Share by Region (2016-2027)
Figure 61. Asia Pacific Plasma-derived Medicinal Products Revenue Share by Region (2016-2027)
Figure 62. China Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 63. Japan Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 64. South Korea Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 65. India Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 66. Australia Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 67. China Taiwan Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 68. Indonesia Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 69. Thailand Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 70. Malaysia Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 71. Latin America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 72. Latin America Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 73. Latin America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 74. Latin America Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 75. Latin America Plasma-derived Medicinal Products Sales Share by Country (2016-2027)
Figure 76. Latin America Plasma-derived Medicinal Products Revenue Share by Country (2016-2027)
Figure 77. Mexico Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 78. Brazil Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 79. Argentina Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Plasma-derived Medicinal Products Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Plasma-derived Medicinal Products Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Plasma-derived Medicinal Products Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Plasma-derived Medicinal Products Revenue Share by Country (2016-2027)
Figure 86. Turkey Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 88. UAE Plasma-derived Medicinal Products Revenue (2016-2027) & (US$ Million)
Figure 89. Plasma-derived Medicinal Products Value Chain
Figure 90. Plasma-derived Medicinal Products Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
注射用組換え凝固Ⅷ因子のグローバル市場インサイト・予測（～2027年） Recombinant Coagulation Factor VIII for Injection, This product is used in the treatment of haemophilia A with plasma coagulation factor VIII (F VIII) deficiency. It acts as a temporary substitute for the missing clotting factor in the correction or prevention of bleeding, emergency or elective surg…- 植物由来甘味料のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Plant-derived Sweetener Market The global Plant-derived Sweetener market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Plant-derived Sweetener Scope and Segment Plant-d…
- プラズマ重合システムのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Plasma Polymerization System Market The global Plasma Polymerization System market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Plasma Polymerization System Sc…
- 血漿採取システムのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Plasma Collection System Market The global Plasma Collection System market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Plasma Collection System Scope and Segm…
- 医薬品用坐剤のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Medicinal Suppositories Market The global Medicinal Suppositories market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Medicinal Suppositories Scope and Segment Medicin…